Cinzia Lanzi

8.9k total citations
73 papers, 2.4k citations indexed

About

Cinzia Lanzi is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cinzia Lanzi has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 30 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cinzia Lanzi's work include Cancer-related Molecular Pathways (14 papers), Thyroid Cancer Diagnosis and Treatment (10 papers) and Proteoglycans and glycosaminoglycans research (9 papers). Cinzia Lanzi is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Thyroid Cancer Diagnosis and Treatment (10 papers) and Proteoglycans and glycosaminoglycans research (9 papers). Cinzia Lanzi collaborates with scholars based in Italy, United States and Switzerland. Cinzia Lanzi's co-authors include Giuliana Cassinelli, Franco Zunino, Nadia Zaffaroni, Paola Perego, Marco A. Pierotti, Laura Gatti, Monica Tortoreto, Italia Bongarzone, Valentina Zuco and Giuditta Cuccuru and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Cinzia Lanzi

73 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cinzia Lanzi Italy	33	1.5k	895	368	345	317	73	2.4k
Giuliana Cassinelli Italy	32	1.4k 0.9×	1.0k 1.1×	373 1.0×	332 1.0×	356 1.1×	64	2.5k
Richard Kendall United States	24	1.8k 1.2×	837 0.9×	236 0.6×	186 0.5×	476 1.5×	43	3.0k
Daniela Califano Italy	29	1.6k 1.0×	964 1.1×	258 0.7×	289 0.8×	577 1.8×	62	2.6k
David Lebwohl United States	18	1.8k 1.2×	1.1k 1.3×	181 0.5×	172 0.5×	360 1.1×	31	3.2k
Christopher J. Molloy United States	29	1.7k 1.1×	733 0.8×	332 0.9×	202 0.6×	220 0.7×	60	2.8k
Mathias Schmidt Germany	25	1.3k 0.8×	1.1k 1.2×	451 1.2×	97 0.3×	278 0.9×	59	2.2k
Sébastien Jeay Switzerland	24	1.1k 0.7×	631 0.7×	154 0.4×	347 1.0×	320 1.0×	46	1.8k
Elizabeth Buck United States	19	1.6k 1.1×	1.1k 1.2×	114 0.3×	483 1.4×	544 1.7×	54	2.8k
Stephen Hiscox United Kingdom	36	2.1k 1.4×	1.4k 1.6×	362 1.0×	161 0.5×	629 2.0×	93	3.8k
Elaine Kilgour United Kingdom	30	2.3k 1.5×	949 1.1×	221 0.6×	288 0.8×	677 2.1×	80	3.5k

Countries citing papers authored by Cinzia Lanzi

Since Specialization

Citations

This map shows the geographic impact of Cinzia Lanzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinzia Lanzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinzia Lanzi more than expected).

Fields of papers citing papers by Cinzia Lanzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinzia Lanzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinzia Lanzi. The network helps show where Cinzia Lanzi may publish in the future.

Co-authorship network of co-authors of Cinzia Lanzi

This figure shows the co-authorship network connecting the top 25 collaborators of Cinzia Lanzi. A scholar is included among the top collaborators of Cinzia Lanzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinzia Lanzi. Cinzia Lanzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanzi, Cinzia, Noemi Arrighetti, Sandro Pasquali, & Giuliana Cassinelli. (2023). Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors. Biochemical Pharmacology. 215. 115727–115727. 10 indexed citations

Cassinelli, Giuliana & Cinzia Lanzi. (2020). Heparanase: A Potential Therapeutic Target in Sarcomas. Advances in experimental medicine and biology. 1221. 405–431. 4 indexed citations

Lanzi, Cinzia & Giuliana Cassinelli. (2020). Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities. Biochemical Pharmacology. 178. 114084–114084. 26 indexed citations

Cassinelli, Giuliana, Laura Dal Bo, Enrica Favini, et al.. (2017). Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases. Cancer Letters. 415. 187–197. 25 indexed citations

Cassinelli, Giuliana, Enrica Favini, Laura Dal Bo, et al.. (2016). Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases. Oncotarget. 7(30). 47848–47863. 38 indexed citations

Corno, Cristina, Laura Gatti, Cinzia Lanzi, et al.. (2016). Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells. Current Medicinal Chemistry. 23(15). 1496–1512. 39 indexed citations

Costa, Barbara, Giulia Donvito, Luca Gabrielli, et al.. (2016). Synthetic sulfoglycolipids targeting the serine–threonine protein kinase Akt. Bioorganic & Medicinal Chemistry. 24(16). 3396–3405. 8 indexed citations

Zuco, Valentina, Giuliana Cassinelli, Giacomo Cossa, et al.. (2015). Targeting the invasive phenotype of cisplatin-resistant Non-Small Cell Lung Cancer cells by a novel histone deacetylase inhibitor. Biochemical Pharmacology. 94(2). 79–90. 19 indexed citations

Gatti, Laura, Giuliana Cassinelli, Nadia Zaffaroni, Cinzia Lanzi, & Paola Perego. (2015). New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants. Drug Resistance Updates. 20. 1–11. 50 indexed citations

10.

Cossa, Giacomo, Cinzia Lanzi, Giuliana Cassinelli, et al.. (2014). Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells. Cancer Letters. 347(2). 212–224. 26 indexed citations

11.

Cassinelli, Giuliana, Cinzia Lanzi, Monica Tortoreto, et al.. (2013). Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models. Biochemical Pharmacology. 85(10). 1424–1432. 72 indexed citations

12.

Degl’Innocenti, Debora, Paola Romeo, Eva Tarantino, et al.. (2012). DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Endocrine Related Cancer. 20(1). 23–37. 45 indexed citations

13.

Shafat, Itay, Josephine Issakov, Isaac Meller, et al.. (2010). Pre-clinical and clinical significance of heparanase in Ewing’s sarcoma. Journal of Cellular and Molecular Medicine. 15(9). 1857–1864. 46 indexed citations

14.

Cassinelli, Giuliana, Domenica Ronchetti, Diletta Laccabue, et al.. (2009). Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting. Biochemical Pharmacology. 78(9). 1139–1147. 8 indexed citations

15.

Lanzi, Cinzia, et al.. (2008). Targeting RET for thyroid cancer therapy. Biochemical Pharmacology. 77(3). 297–309. 48 indexed citations

16.

Petrangolini, Giovanna, Giuditta Cuccuru, Cinzia Lanzi, et al.. (2006). Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1. Biochemical Pharmacology. 72(4). 405–414. 31 indexed citations

17.

Petrangolini, Giovanna, Giuliana Cassinelli, Graziella Pratesi, et al.. (2004). Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft. British Journal of Cancer. 90(7). 1464–1468. 13 indexed citations

18.

Pratesi, Graziella, Diletta Laccabue, Cinzia Lanzi, et al.. (2003). IDN 5390: an oral taxane candidate for protracted treatment schedules. British Journal of Cancer. 88(6). 965–972. 16 indexed citations

19.

Lanzi, Cinzia, Paola Perego, Rosanna Supino, et al.. (1998). Decreased Drug Accumulation and Increased Tolerance to DNA Damage in Tumor Cells with a Low Level of Cisplatin Resistance - circumvention studies using novel platinum (II) and (IV) ammine/amine complexes. Biochemical Pharmacology. 8(55). 1247–1254. 1 indexed citations

20.

Lanzi, Cinzia, Virgilio Gallai, Lucia Margari, et al.. (1997). DESMOPRESSIN AND IMIPRAMINE IN THE MANAGEMENT OF NOCTURNAL ENURESIS: A MULTICENTRE STUDY. International Journal of Clinical Practice. 51(1). 27–31. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact